Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits

Frank Buttgereit; Andriko Palmowski; Idil Esen; Elisabeth Brouwer

doi:10.1002/art.42414

Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits

Frank Buttgereit, Andriko Palmowski, Idil Esen, Elisabeth Brouwer

Parker Instituttet

Originalsprog	Engelsk
Tidsskrift	Arthritis and Rheumatology
Vol/bind	75
Udgave nummer	4
Sider (fra-til)	489-492
Antal sider	4
ISSN	2326-5191
DOI	https://doi.org/10.1002/art.42414
Status	Udgivet - apr. 2023

Adgang til dokumentet

10.1002/art.42414

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{63b8a6e71e844c80847797fbe026f3d3,

title = "Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits",

keywords = "Humans, Giant Cell Arteritis/drug therapy, Antibodies, Monoclonal, Humanized/therapeutic use, Glucocorticoids",

author = "Frank Buttgereit and Andriko Palmowski and Idil Esen and Elisabeth Brouwer",

year = "2023",

month = apr,

doi = "10.1002/art.42414",

language = "English",

volume = "75",

pages = "489--492",

journal = "Arthritis and Rheumatology",

issn = "2326-5191",

publisher = "John Wiley and Sons Ltd",

number = "4",

}

TY - JOUR

T1 - Tocilizumab in Giant Cell Arteritis

T2 - Better Understanding the Benefits

AU - Buttgereit, Frank

AU - Palmowski, Andriko

AU - Esen, Idil

AU - Brouwer, Elisabeth

PY - 2023/4

Y1 - 2023/4

KW - Humans

KW - Giant Cell Arteritis/drug therapy

KW - Antibodies, Monoclonal, Humanized/therapeutic use

KW - Glucocorticoids

UR - http://www.scopus.com/inward/record.url?scp=85147276743&partnerID=8YFLogxK

U2 - 10.1002/art.42414

DO - 10.1002/art.42414

M3 - Journal article

C2 - 36468520

SN - 2326-5191

VL - 75

SP - 489

EP - 492

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

IS - 4

ER -